Study Claims Amgen's Kyprolis More Effective Than Takeda's Velcade In a study, Amgen drug Kyprolis outperformed Takeda’s Velcade in efficacy as treament for relapsed multiple myeloma in combination with low-dose dexamethasone. by Dianne Depra
China Launches World's Largest Electric Container Ship, Slashing 8,600 Pounds of Emissions per 100 Nautical Miles